Dr. Sundaram is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Icahn School of Medicine at Mount Sinai
1425 Madison Ave
New York, NY 10029
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
Cleveland Clinic FoundationResidency, Internal Medicine, 2012 - 2015
L. Tilak Municipal Medical CollegeClass of 2011
Certifications & Licensure
NY State Medical License 2018 - 2025
OH State Medical License 2012 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL Start of enrollment: 2021 Feb 19
Roles: Principal Investigator, Contact
- Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas Start of enrollment: 2018 Mar 16
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Targeted BET inhibition with OPN-51107 synergizes with venetoclax in chronic lymphocytic leukemia.Kevin G Zablonski, Sydney A Skupa, Alexandria P Eiken, Suchitra Sundaram, Cory Mavis
Leukemia & Lymphoma. 2024-12-01 - High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series.Narendranath Epperla, Adam S Zayac, Daniel J Landsburg, Allison M Bock, Grzegorz S Nowakowski
Blood Advances. 2024-10-22 - 9 citationsHigh-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study.Adam S Zayac, Daniel J Landsburg, Mitchell E Hughes, Allison M Bock, Grzegorz S Nowakowski
Blood Advances. 2023-11-14
Abstracts/Posters
- Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...Suchitra Sundaram, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Outcomes of Patients with Refractory Peripheral T-Cell Lymphoma, Angioimmunoblastic and Other Nodal Lymphomas of T Follicular Helper-Cell Origin (OPerA)Suchitra Sundaram, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)Suchitra Sundaram, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Utility of Bone Marrow Biopsy in the Staging of T-Cell Lymphoma in the PET-CT Era61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Early Complete Remission By Functional Imaging and Intensified Frontline Therapy Are Associated with an Improved Clinical Outcome in Patients with Newly Diagnosed T-Ce...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
Addressing Disparities in DLBCL Treatment and OutcomesJanuary 27th, 2025- Reflections on an Early DLBCL Case and the Evolving Treatment LandscapeJanuary 27th, 2025
- R2 Maintenance for Elderly MCL Patients Worth the Risk?December 13th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
